About Us
We are building on our team’s exceptional track record of FDA-approved precision medicines to create the next leap forward in oncology and autoimmune diseases.
Science
Combining human intelligence, creative thinking and proven drug design expertise, we tackle some of the biggest challenges in oncology and autoimmune diseases.
Pipeline
Medicines built from the ground up that aim to overcome the limitations of existing therapies.
Clinical Trials
Explore our clinical trials and learn about how you can participate.
BlossomHill Therapeutics Chief Executive Officer Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering
February 14, 2024